Immunology The goals of the Immunology Program are to promote basic and translational science focusing on cancer immunobiology and to promote an environment conducive to intra and interprogrammatic collaborations. These goals are achieved by the recruitment and retention of outstanding basic and translational scientists, and the promotion of interactions with clinicians in the NC Cancer Hospital. The 25 members'research is organized into two major themes, innate and adaptive immunity. Within each of the themes are multiple subthemes with the innate immune theme focusing on cancer and inflammation with a spot light on colitis and colorectal cancer and hepatitis and hepatocellular carcinoma. Additional subthemes include dendritic cell biology, interactions between immune response and radiation biology, and novel pattern sensing receptors. The adaptive immune program is divided into three subthemes that include vaccine development, graft-versus-host biology and the role of migratory proteins in the interaction between T and B lymphocytes, tumor cells and the stroma. Research highlights include: (1) completion of the first clinical trial combining standard therapy with vaccine treatment for patients with breast cancer;(2) identification of the first mitochondrial NLR protein that recognizes viral nucleic acid;(3) preclinical development of an IKK inhibitor for the prevention of GvHD;(4) identification of novel pathways in which chemokines interact with migrating stromal cells to promote pulmonary metastasis;(5) new models and Insights into the interaction of innate immune cells as critical mediators of carcinogenesis in the Gl tract;and (6) the development of novel humanized mouse models to explore the interaction between the human immune system and the development of cancer. The program addes value to the Cancer Center by promoting preclinical studies into clinical therapies, forging collaborations between scientists, generating new collaborations between scientists and clinicians via retreats and monthly meetings, and providing funding support for novel translational and basic investigations. The program is led by Dr. Jenny Ting, Ph.D., a leader in innate and molecular immunology and Dr. Jonathan Serody, M.D., a leader in cellular immunology, In vivo imaging and vaccine development. In 2009 the program's 25 members had extramural funding totaling $16.2M (total costs).

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA016086-37
Application #
8392158
Study Section
Subcommittee G - Education (NCI)
Project Start
Project End
Budget Start
2012-12-01
Budget End
2013-11-30
Support Year
37
Fiscal Year
2013
Total Cost
$170,333
Indirect Cost
$72,665
Name
University of North Carolina Chapel Hill
Department
Type
DUNS #
608195277
City
Chapel Hill
State
NC
Country
United States
Zip Code
27599
Lim, Joseph K; Liapakis, Ann Marie; Shiffman, Mitchell L et al. (2018) Safety and Effectiveness of Ledipasvir and Sofosbuvir, With or Without Ribavirin, in Treatment-Experienced Patients With Genotype 1 Hepatitis C Virus Infection and Cirrhosis. Clin Gastroenterol Hepatol 16:1811-1819.e4
Wang, Gary P; Terrault, Norah; Reeves, Jacqueline D et al. (2018) Prevalence and impact of baseline resistance-associated substitutions on the efficacy of ledipasvir/sofosbuvir or simeprevir/sofosbuvir against GT1 HCV infection. Sci Rep 8:3199
Phillips, Bonnie; Van Rompay, Koen K A; Rodriguez-Nieves, Jennifer et al. (2018) Adjuvant-Dependent Enhancement of HIV Env-Specific Antibody Responses in Infant Rhesus Macaques. J Virol 92:
Lianga, Noel; Doré, Carole; Kennedy, Erin K et al. (2018) Cdk1 phosphorylation of Esp1/Separase functions with PP2A and Slk19 to regulate pericentric Cohesin and anaphase onset. PLoS Genet 14:e1007029
Allott, Emma H; Geradts, Joseph; Cohen, Stephanie M et al. (2018) Frequency of breast cancer subtypes among African American women in the AMBER consortium. Breast Cancer Res 20:12
Dhungel, Bal Mukunda; Montgomery, Nathan D; Painschab, Matthew S et al. (2018) 'Discovering' primary effusion lymphoma in Malawi. AIDS 32:2264-2266
Cameron, Jennifer E; Rositch, Anne F; Vielot, Nadja A et al. (2018) Epstein-Barr Virus, High-Risk Human Papillomavirus and Abnormal Cervical Cytology in a Prospective Cohort of African Female Sex Workers. Sex Transm Dis 45:666-672
Stanley, Christopher C; van der Gronde, Toon; Westmoreland, Kate D et al. (2018) Risk factors and reasons for treatment abandonment among children with lymphoma in Malawi. Support Care Cancer 26:967-973
Dronamraju, Raghuvar; Jha, Deepak Kumar; Eser, Umut et al. (2018) Set2 methyltransferase facilitates cell cycle progression by maintaining transcriptional fidelity. Nucleic Acids Res 46:1331-1344
Koehler, Jennifer W; Miller, Andrew D; Miller, C Ryan et al. (2018) A Revised Diagnostic Classification of Canine Glioma: Towards Validation of the Canine Glioma Patient as a Naturally Occurring Preclinical Model for Human Glioma. J Neuropathol Exp Neurol 77:1039-1054

Showing the most recent 10 out of 1525 publications